首页> 外国专利> TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE THAT INDUCES HIGH LEVELS OF ROTIGOTINE IN PLASMA.

TRANSDERMAL THERAPEUTIC SYSTEM FOR PARKINSON'S DISEASE THAT INDUCES HIGH LEVELS OF ROTIGOTINE IN PLASMA.

机译:帕金森病的经皮治疗系统,可诱导血浆中高水平的旋转蛋白。

摘要

A silicone-based transdermal therapeutic system comprising a mixture of at least one high adhesion silicone contact adhesive and at least one of medium adhesion as the main adhesive components, which has an area of 10 to 40 cm 2 and containing 0.1 to 3.15 mg / cm 2 of free base rotigotine as an active ingredient, in which the silicone-based transdermal system is suitable for inducing an average plasma rotigotine concentration within the range of 0, 4 to 2 ng / ml 24 h after administration.
机译:一种有机硅基透皮治疗系统,其包含至少一种高附着力有机硅接触性粘合剂和中等附着力中的至少一种作为主要粘合剂成分的混合物,其面积为10至40 cm 2,并且含有0.1至3.15 mg / cm 2以游离碱罗替戈汀为有效成分,其中基于硅氧烷的透皮系统适合于在给药后24小时内诱导0、4至2 ng / ml范围内的平均血浆罗替戈汀浓度。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号